12 Health Care Stocks Moving In Friday's After-Market Session

Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera

The global synthetic antibody library market is projected to grow from $1.63 billion in 2025 to $2.86 billion by 2030, representing a 12% CAGR. Growth is driven by AI-integrated antibody design, increased demand for therapeutic antibodies, high-throughput screening technologies, and expansion of contract research organizations. North America leads the market while Asia-Pacific shows fastest growth potential.

UBS Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $18

AbCellera Presents Phase 1/2 Data On ABCL635 At TMS 2026 Annual Meeting

JP Morgan Initiates Coverage On AbCellera Biologics with Overweight Rating, Announces Price Target of $17

Akanda Corp. Files Registration Withdrawal Request

Akanda Corp. has submitted a request for the withdrawal of a registration statement.

Akanda Determined That It Was No Longer Going To Pursue The Cultivation Of Cannabis Or Any Future Cannabis-Related Businesses; Going To Focus Its Business Efforts On Growth, Management Of Its First Towers & Fibers Corp. Subsidiary, Potentially Other Business Targets; Declined To Pay Next Option Payment Due Under Its Amended And Restated Option To Purchase Agreement With 1107385 B.C. LTD; Company’s Right To Acquire Or Use The BC Property Under The Option Agreement Has Been Terminated

On September 24, 2026, the Board of Directors of Akanda Corp. (the "Company") determined that it was no longer going to pursue the cultivation of cannabis or any future cannabis-related businesses, including its